Business Description
Founded in 2011 and based in Rockville, Maryland, Avalo Therapeutics is a U.S. biotech company working to bring new treatments to patients whose immune systems cause harmful inflammation. The company's most advanced drug candidate, AVTX-009, is currently being tested in a mid-stage clinical trial targeting a protein linked to inflammatory conditions. Previously operating under the name Cerecor Inc., the company rebranded as Avalo Therapeutics in August 2021.
